Stockscreener 앱 받기
0.2225
7.60%
-0.0183
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio conditionally regains Nasdaq compliance with equity listing rule By Investing.com - Investing.com Nigeria
GRI Bio conditionally regains Nasdaq compliance with equity listing rule - Investing.com
GRI Bio Regains Conditional Compliance With Nasdaq Listing Requirements - TipRanks
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
GRI Bio Shareholders Authorize Reverse Stock Split Plan - TipRanks
GRI Bio shareholders approve reverse stock split and report Nasdaq compliance - Investing.com
GRI Bio (NASDAQ: GRI) wins reverse split approval and addresses Nasdaq equity risk - Stock Titan
GRI: Reverse stock split and adjournment proposals approved; results to be filed on Form 8-K - TradingView — Track All Markets
Gains Recap: Why GRI Bio Inc stock remains on watchlistsJuly 2025 Big Picture & Low Risk Investment Opportunities - Bộ Nội Vụ
Options Flow: What insider trading reveals about GRI Bio Inc. stockEarnings Trend Report & Smart Money Movement Alerts - Bộ Nội Vụ
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Market Recap: What makes GRI Bio Inc stock attractive todayJuly 2025 Snapshot & Fast Moving Trade Plans - baoquankhu1.vn
GRI Bio approves reverse stock split, stockholders vote in favor - MSN
GRI Bio, Inc.Common Stock (NQ: GRI - FinancialContent
GRI Bio announces pricing of $8M public offering - MSN
GRI Bio increases at-the-market offering capacity to $7.38 million - Investing.com Australia
GRI Bio reports positive Phase 2a data for IPF treatment By Investing.com - Investing.com Nigeria
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio, Inc. Increases Share Issuance Limit - TradingView — Track All Markets
Can GRI Bio Inc. stock sustain institutional interestCushioning Options Review & trail grip notes for mixed terrain - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is GRI Bio Inc. stock affected by interest rate hikesWall Street Watch & Safe Entry Trade Signal Reports - Улправда
Can GRI Bio Inc. stock weather global recession2025 Price Targets & Community Consensus Trade Signals - ulpravda.ru
GRI Bio stock rises on positive Phase 2a immune data for IPF treatment - Investing.com
GRI Bio reports positive Phase 2a data for IPF treatment - Investing.com
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 - The Manila Times
GRI Bio, Inc. Announces Positive Phase 2a Trial Data for GRI-0621 - TradingView — Track All Markets
GRI Bio Announces Additional Positive Data from Phase 2a - GlobeNewswire
GRI Bio reports six-week interim safety outcomes from trial of GRI-0621 for IPF - MSN
What Wall Street predicts for GRI Bio Inc. stock priceBullish Engulfing Patterns & Small Entry Portfolio - Улправда
What technical signals suggest for GRI Bio Inc. stock2026 world cup usa national team third place match goalkeepers high defensive line group prediction insights - Улправда
What drives GRI Bio Inc stock priceEarnings Forecast Updates & High Yield Trading Growth - Early Times
Decliners Report: Is GRI Bio Inc stock attractive for hedge funds2025 Bull vs Bear & Free Community Consensus Stock Picks - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about GRI Bio Inc. stockLong Setup & Real-Time Buy Zone Alerts - Улправда
Why GRI Bio Inc. stock remains on buy listsWeekly Trade Analysis & Weekly Setup with High ROI Potential - Улправда
Why GRI Bio Inc. stock could be next big winnerJuly 2025 Intraday Action & Expert Approved Momentum Ideas - DonanımHaber
What sentiment indicators say about GRI Bio Inc. stockWeekly Market Outlook & Weekly Momentum Stock Picks - Улправда
Oral therapy GRI-0621 boosts lung function, repairs tissue in IPF: Data - Pulmonary Fibrosis News
GRI Bio announces GRI-0621-IPF-02 trial met primary, secondary endpoints - MSN
GRI Bio Closes $8 Million Public Offering - The Globe and Mail
GRI Bio closes $8 million public offering of common stock and warrants - Investing.com Nigeria
GRI Bio closes $8 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
GRI Bio (Nasdaq: GRI) details closing of offering, equity over $2.5M post-transaction - Stock Titan
GRI Bio Announces Closing of $8.0 Million Public Offering - GlobeNewswire
GRI Bio Launches $6.7 Million Public Offering - TipRanks
GRI Bio (NASDAQ: GRI) details $6.7M equity deal and runway into Q4 2026 - Stock Titan
GRI Bio prices $8 million public offering at $0.75 per share - Investing.com
GRI Bio’s IPF drug shows positive Phase 2a results with improved lung function - Investing.com India
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
GRI Bio Announces Pricing of $8,000,000 Million Public Offering - The Manila Times
GRI Bio (NASDAQ: GRI) prices $8,000,000 offering of 10,666,667 shares at $0.75 - Stock Titan
4.73%
0.92%
자본화:
|
볼륨(24시간):